Castéra Laurent, Pedeboscq Anne, Rocha Marcia, Le Bail Brigitte, Asencio Corinne, de Lédinghen Victor, Bernard Pierre-Henri, Laurent Christophe, Lafon Marie-Edith, Capdepont Maylis, Couzigou Patrice, Bioulac-Sage Paulette, Balabaud Charles, Mégraud Francis, Ménard Armelle
Service d'Hépato-Gastroentérologie, Hôpital St-André, Bordeaux, France.
World J Gastroenterol. 2006 Dec 7;12(45):7278-84. doi: 10.3748/wjg.v12.i45.7278.
To determine the presence of Helicobacter species DNA in the liver of chronic hepatitis C (CHC) patients with and without cirrhosis as compared to controls, and to identify the bacterial species involved.
Seventy-nine consecutive patients (HBV and HIV negative) with a liver sample obtained after liver biopsy or hepatic resection were studied: 41 with CHC without cirrhosis, 12 with CHC and cirrhosis, and 26 controls (HCV negative). Polymerase chain reactions (PCRs) targeting Helicobacter 16S rDNA and species-specific were performed on DNA extracted from the liver. A gastric infection with H pylori was determined by serology and confirmed by 13C-urea breath test.
Overall, Helicobacter 16S rDNA was found in 16 patients (20.2%). Although positive cases tended to be higher in CHC patients with cirrhosis (41.6%) than in those without cirrhosis (17.0%) or in controls (15.4%), the difference was not statistically significant (P = 0.08). H pylori-like DNA was identified in 12 cases and H. pullorum DNA in 2, while 2 cases remained unidentified. Gastric infection with H pylori was found in only 2 of these patients.
Our results do not confirm the association of Helicobacter species DNA in the liver of CHC patients with advanced liver disease. The lack of correlation between positive H pylori serology and the presence of H pylori-like DNA in the liver may indicate the presence of a variant of this species.
比较慢性丙型肝炎(CHC)患者(有或无肝硬化)与对照组肝脏中幽门螺杆菌属DNA的存在情况,并鉴定其中涉及的细菌种类。
对79例连续患者(乙肝和艾滋病毒阴性)进行研究,这些患者均在肝活检或肝切除后获取了肝脏样本:41例无肝硬化的CHC患者,12例有肝硬化的CHC患者,以及26例对照组(丙肝病毒阴性)。对从肝脏中提取的DNA进行靶向幽门螺杆菌16S rDNA和种属特异性的聚合酶链反应(PCR)。通过血清学检测确定幽门螺杆菌的胃部感染,并通过13C-尿素呼气试验进行确认。
总体而言,在16例患者(20.2%)中发现了幽门螺杆菌16S rDNA。虽然有肝硬化的CHC患者中阳性病例倾向于高于无肝硬化的患者(41.6%)或对照组(15.4%),但差异无统计学意义(P = 0.08)。在12例病例中鉴定出幽门螺杆菌样DNA,2例中鉴定出鸡幽门螺杆菌DNA,而2例仍未鉴定。这些患者中仅2例发现有幽门螺杆菌的胃部感染。
我们的结果未证实晚期肝病CHC患者肝脏中幽门螺杆菌属DNA的关联。幽门螺杆菌血清学阳性与肝脏中幽门螺杆菌样DNA的存在之间缺乏相关性,这可能表明该菌种存在变异体。